* Oscar Health Inc OSCR.N reported a quarterly adjusted
loss
of 62 cents per share for the quarter ended December 31,
higher than the same quarter last year, when the company
reported EPS of -66 cents. The mean expectation of
eight analysts for the quarter was for a loss of 59 cents per
share. Wall Street expected results to range from -68 cents
to -48 cents per share.
* Revenue rose 67.1% to $2.39 billion from a year ago;
analysts
expected $2.47 billion.
* Oscar Health Inc's reported EPS for the quarter was a loss
of 62
cents.
* The company reported a quarterly loss of $153.55 million.
* Oscar Health Inc shares had risen by 24.6% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 3.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and 2 "sell" or "strong sell."
* The average consensus recommendation for the life & health
insurance peer group is also "hold"
Wall Street's median 12-month price target for Oscar Health Inc
is $19.00
This summary was machine generated from LSEG data February 4 at
10:54 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 -0.59 -0.62 Missed
Sep. 30 2024 -0.17 -0.22 Missed
Jun. 30 2024 0.16 0.20 Beat
Mar. 31 2024 0.27 0.62 Beat